Aurora kinase A is a synthetic lethal target in FANCA-deficient cancers

npj Precision Oncology · Published 2026-07-11 · DOI 10.1038/s41698-026-01596-7

Free full text

Authors (31)

Dilara Akhoundova, Martín González-Fernández, Aavash Baral, Andrej Benjak, Carmen Perry, Dinda Shezaria Hardy Lubis, Ladina Hörtensteiner, Saskia Hussung, Lea Lingg, Sina Maletti, Aino Paasinen-Sohns, Marika Lehner, Bastian Dislich, Erik Vassella, Simone de Brot, Therese Waldburger, Petros Tsiridis, Carmen Cardozo, Ralph Fritsch, Clelia Pistoni, Seynabou Diop, Phillip Thienger, Taina Kaiponen, Muriel Jaquet, Mariana Ricca, Smruthy Sivakumar, Christopher McDermott-Roe, David E. Root, Paola Francica, Sven Rottenberg, Mark A. Rubin

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Akhoundova, D., González-Fernández, M., Baral, A., et al. (2026). Aurora kinase A is a synthetic lethal target in FANCA-deficient cancers. npj Precision Oncology. https://doi.org/10.1038/s41698-026-01596-7

Related articles

• Anaplastic thyroid cancer: review of precision therapy options and advances · npj Precision Oncology · 2026 · Same journal
• Integrated prediction of lung cancer histology and molecular profiles from small bronchoscopic tumor specimens · npj Precision Oncology · 2026 · Same journal
• Comprehensive multi-omic dissection and AI-prioritized target identification in inverted papilloma–associated sinonasal squamous cell carcinoma · npj Precision Oncology · 2026 · Same journal
• snRNA-seq of acral melanoma reveals heterogeneity and identifies novel progression marker and cancer-associated fibroblasts subpopulation · npj Precision Oncology · 2026 · Same journal
• Prediction of single cell expression from low-plex immunofluorescence images for guiding precision oncology · npj Precision Oncology · 2026 · Same journal
• Single-cell ploidy analysis reveals polyploidy effects on tumor aggressiveness and immune suppression in intrahepatic cholangiocarcinoma · npj Precision Oncology · 2026 · Same journal
• Discordance in molecular classification of primary and metastatic endometrial cancer: implications for precision treatment · npj Precision Oncology · 2026 · Same journal
• Patient cell drug profiling identifies p53-linked vulnerabilities in refractory lymphoid malignancies · npj Precision Oncology · 2026 · Same journal
• Deep learning-based segmentation and subtype prediction of renal cell carcinoma on contrast-enhanced CT · npj Precision Oncology · 2026 · Same journal
• Prognostic impact of somatic mutations among patients with pleural and peritoneal mesothelioma · npj Precision Oncology · 2026 · Same journal